Liomont
3 articles about Liomont
-
Liomont Signs Commercial License Agreement With Selexis SA For Use Of Proprietary Cell Line And Suretechnology Platform
6/2/2016
-
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market
8/12/2014
-
Liomont And Oncobiologics Inc. Partner To Launch Biosimilars In Mexico
6/26/2014